SOD2 is a regulator of proteasomal degradation promoting an adaptive cellular starvation response.

Saved in:
Bibliographic Details
Title: SOD2 is a regulator of proteasomal degradation promoting an adaptive cellular starvation response.
Authors: Ibrahim NK; Department of Pediatric Hematology and Oncology, Hannover Medical School, 30625 Hannover, Germany., Schreek S; Department of Pediatric Hematology and Oncology, Hannover Medical School, 30625 Hannover, Germany., Cinar B; Department of Pediatric Hematology and Oncology, Hannover Medical School, 30625 Hannover, Germany., Stasche AS; Department of Pediatric Hematology and Oncology, Hannover Medical School, 30625 Hannover, Germany., Lee SH; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA., Zeug A; Department of Cellular Neurophysiology, Hannover Medical School, 30625 Hannover, Germany., Dolgner T; Department of Pediatric Hematology and Oncology, Hannover Medical School, 30625 Hannover, Germany., Niessen J; Department of Pediatric Hematology and Oncology, Hannover Medical School, 30625 Hannover, Germany., Ponimaskin E; Department of Cellular Neurophysiology, Hannover Medical School, 30625 Hannover, Germany., Shcherbata H; Department of Cell Biochemistry, Hannover Medical School, 30625 Hannover, Germany; Mount Desert Island Biological Laboratory, Bar Harbor, ME 04609, USA., Fehlhaber B; Department of Pediatric Hematology and Oncology, Hannover Medical School, 30625 Hannover, Germany., Bourquin JP; Department of Pediatric Hematology/Oncology, University Children's Hospital, 8032 Zurich, Switzerland., Bornhauser B; Department of Pediatric Hematology/Oncology, University Children's Hospital, 8032 Zurich, Switzerland., Stanulla M; Department of Pediatric Hematology and Oncology, Hannover Medical School, 30625 Hannover, Germany., Pich A; Institute of Toxicology, Research Core Unit - Proteomics, Hannover Medical School, 30625 Hannover, Germany., Gutierrez A; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA; Department of Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA; Department of Pediatric Oncology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA., Hinze L; Department of Pediatric Hematology and Oncology, Hannover Medical School, 30625 Hannover, Germany. Electronic address: hinze.laura@mh-hannover.de.
Source: Cell reports [Cell Rep] 2025 Apr 22; Vol. 44 (4), pp. 115434. Date of Electronic Publication: 2025 Mar 24.
Publication Type: Journal Article
Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 101573691 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2211-1247 (Electronic) NLM ISO Abbreviation: Cell Rep Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2211-1247
DOI:10.1016/j.celrep.2025.115434